CytoDyn (CYDY) shareholders experienced a big letdown following its exhilarating, albeit brief, sprint to $10.00 back in late July. Now, one short month later [pun intended], the floor seems to have fallen away. CytoDyn has breached the $3.00 level on several occasions recently.
On Friday, 08/21/20, a slight recovery started. I anticipate that this will continue over the near term. I remain cautiously bullish on CytoDyn's COVID-19 prospects going forward as I will explain in this article. I consider that its downdraft was overdone and that it will likely correct part of the overreaction.